USC-LED STUDY SUGGESTS LITTLE BENEFIT FROM ANTIPSYCHOTICS IN ALZHEIMER'S

Most Alzheimer's patients prescribed antipsychotic drugs for delusions, agitation or aggression do no better than those who take a placebo because so many discontinue the drugs due to significant side effects, according to a major new nationwide study led by Lon Schneider, professor of psychiatry, neurology and gerontology at the Keck School of Medicine of the University of Southern California (USC).

EurekAlert! (http://www.eurekalert.org/pub_releases/2006-10/uosc-uls100906.php)